+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort



Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort



Respiratory Medicine 117: 272-279



Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from various comorbidities. Recently, cluster analysis has been proposed to examine the phenotypic heterogeneity in COPD. In order to comprehensively understand the comorbidities of COPD in Japan, we conducted multicenter, longitudinal cohort study, called the Keio COPD Comorbidity Research (K-CCR). In this cohort, comorbid diagnoses were established by both objective examination and review of clinical records, in addition to self-report. We aimed to investigate the clustering of nineteen clinically relevant comorbidities and the meaningful outcomes of the clusters over a two-year follow-up period. The present study analyzed data from COPD patients whose data of comorbidities were completed (n = 311). Cluster analysis was performed using Ward's minimum-variance method. Five comorbidity clusters were identified: less comorbidity; malignancy; metabolic and cardiovascular; gastroesophageal reflux disease (GERD) and psychological; and underweight and anemic. FEV1 did not differ among the clusters. GERD and psychological cluster had worse COPD assessment test (CAT) and Saint George's respiratory questionnaire (SGRQ) at baseline compared to the other clusters (CAT: p = 0.0003 and SGRQ: p = 0.00046). The rate of change in these scores did not differ within 2 years. The underweight and anemic cluster included subjects with lower baseline ratio of predicted diffusing capacity (DLco/VA) compared to the malignancy cluster (p = 0.036). Five clusters of comorbidities were identified in Japanese COPD patients. The clinical characteristics and health-related quality of life were different among these clusters during a follow-up of two years.

(PDF emailed within 0-6 h: $19.90)

Accession: 058039281

Download citation: RISBibTeXText

PMID: 27492541

DOI: 10.1016/j.rmed.2016.07.002


Related references

Epidemiology of comorbidities in chronic obstructive pulmonary disease clusters, phenotypes and outcomes. Italian Journal of Medicine 6(4): 276-284, 2012

Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 187(7): 728-735, 2013

Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study. Respiratory Medicine 117: 33-39, 2017

Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease--an overview of the cohort study COSYCONET. Deutsche Medizinische Wochenschrift 135(10): 446-449, 2010

Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. American Journal of Respiratory and Critical Care Medicine 177(4): 396-401, 2007

Physical comorbidities affect physical activity in chronic obstructive pulmonary disease: a prospective cohort study. Respirology 19(6): 866-872, 2015

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. American Journal of Respiratory and Critical Care Medicine 184(6): 662-671, 2012

A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world. International Journal of Chronic Obstructive Pulmonary Disease 10: 2127-2136, 2016

Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Annals of the American Thoracic Society 12(3): 303-312, 2015

Chronic obstructive pulmonary disease and its comorbidities. Panminerva Medica 51(2): 115-123, 2010

Chronic obstructive pulmonary disease and associated comorbidities. Zhonghua Jie He He Hu Xi Za Zhi 36(4): 245-247, 2014

Chronic obstructive pulmonary disease and comorbidities. Lancet. Respiratory Medicine 1(1): 73-83, 2015

Comorbidities in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 5(4): 549-555, 2008

Chronic obstructive pulmonary disease comorbidities. Current Opinion in Pulmonary Medicine 22(2): 113-118, 2016

Comorbidities of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 17 Suppl 1: S21-S28, 2012